Evolve osteoporosis and other guidelines avoiding cognitive bias

被引：0

作者：

O'Donnell, J. L. ^{[1
,2
]}

机构：

[1] Christchurch Hosp, Dept Rheumatol Immunol & Allergy, Christchurch, New Zealand

[2] Canterbury Hlth Labs, Canterbury Dist Hlth Board, Canterbury, New Zealand

来源：

INTERNAL MEDICINE JOURNAL | 2016年 / 46卷 / 10期

关键词：

BONE-MINERAL DENSITY; TOP; 5; LIST; NONVERTEBRAL FRACTURE; RANDOMIZED-TRIAL; ALENDRONATE; RISK; REDUCTION; EXTENSION; WOMEN; BMD;

D O I：

10.1111/imj.13212

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1129 / 1133

页数：5

共 19 条

[1]

[Anonymous], 2000, COCHRANE DB SYST REV

[2] The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) [J].

Black, Dennis M. ;

Reid, Ian R. ;

Boonen, Steven ;

Bucci-Rechtweg, Christina ;

Cauley, Jane A. ;

Cosman, Felicia ;

Cummings, Steven R. ;

Hue, Trisha F. ;

Lippuner, Kurt ;

Lakatos, Peter ;

Leung, Ping Chung ;

Man, Zulema ;

Martinez, Ruvie Lou Maria ;

Tan, Monique ;

Ruzycky, Mary Ellen ;

Su, Guoqin ;

Eastell, Richard .

JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (02) :243-254

[3] Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial [J].

Black, Dennis M. ;

Schwartz, Ann V. ;

Ensrud, Kristine E. ;

Cauley, Jane A. ;

Levis, Silvina ;

Quandt, Sara A. ;

Satterfield, Suzanne ;

Wallace, Robert B. ;

Bauer, Douglas C. ;

Palermo, Lisa ;

Wehren, Lois E. ;

Lombardi, Antonio ;

Santora, Arthur C. ;

Cummings, Steven R. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (24) :2927-2938

[4] Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].

Black, DM ;

Cummings, SR ;

Karpf, DB ;

Cauley, JA ;

Thompson, DE ;

Nevitt, MC ;

Bauer, DC ;

Genant, HK ;

Haskell, WL ;

Marcus, R ;

Ott, SM ;

Torner, JC ;

Quandt, SA ;

Reiss, TF ;

Ensrud, KE .

LANCET, 1996, 348 (9041) :1535-1541

[5] Medicine's Ethical Responsibility for Health Care Reform - The Top Five List [J].

Brody, Howard .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (04) :283-285

[6] Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy [J].

Delmas, PD ;

Seeman, E .

BONE, 2004, 34 (04) :599-604

[7] Bisphosphonates for the Prevention and Treatment of Osteoporosis in Patients with Rheumatic Diseases: A Systematic Review and Meta-Analysis [J].

Feng, Zhiyun ;

Zeng, Shumei ;

Wang, Yue ;

Zheng, Zhiyun ;

Chen, Zhong .

PLOS ONE, 2013, 8 (12)

[8]

Kahneman D., 2011, Thinking, fast and slow

[9] Does osteoporosis therapy invalidate FRAX for fracture prediction? [J].

Leslie, William D. ;

Lix, Lisa M. ;

Johansson, Helena ;

Oden, Anders ;

McCloskey, Eugene ;

Kanis, John A. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (06) :1243-1251

[10] BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronate [J].

McNabb, Brian Louis ;

Vittinghoff, Eric ;

Schwartz, Ann V. ;

Eastell, Richard ;

Bauer, Douglas C. ;

Ensrud, Kristine ;

Rosenberg, Elizabeth ;

Santora, Arthur ;

Barrett-Connor, Elizabeth ;

Black, Dennis M. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (06) :1319-1327

← 1 2 →